21 multiple-sequence-alignment positions at Center for Biological Research "Margarita Salas" CSIC
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
diverse environments in suitable vectors; (iii) adapt existing enzyme assays to droplet format; (iv) screen libraries from metagenomes; v) sequence and structure determination, biochemical and
-
to generate new knowledge that supports the development of sustainable strategies to combat bacterial diseases affecting crops. This aligns with global challenges such as the Paris Agreement on Climate Change
-
of adaptation, using a combination of computational approaches, experimental evolution (of bacteria and single proteins), and omics (sequencing, transcriptomics). The group is part of the Biodiversity Program at
-
diverse environments in suitable vectors; (iii) adapt existing enzyme assays to droplet format; (iv) screen libraries from metagenomes; v) sequence and structure determination, biochemical and
-
. Interest in interdisciplinary and collaborative science. Specific Requirements Desired: · Experience in primary cell culture · Expertise in sequencing library preparation · Hands-on experience with CRISPR
-
this thermosensitive response or that promotes it in the light. He/she will backcross these mutants with cop1-6 and segregate those seedlings in cop1-6 or mutant pools, to map these mutations by sequencing. Will in
-
of digital innovation processes in companies; Work closely with multidisciplinary teams to ensure alignment and innovation; Contribute to other activities that fall within the overall objectives of the project
-
approaches will be developed to design molecules from scratch and are expected balance interaction with multiple targets. Specific goals are: Development of a conditional generation approach for the de novo
-
-being for children and families, aligning with UNICEF's commitment to ensure every child grows up in a safe, nurturing environment with access to mental health and psychosocial support. Findings will
-
bacteria and represents a promising new target to prevent infections or biofouling. Using a patented Q reporter strain and developing multiplate and microfluidic workflows, Q inhibitors will be screened in